The Fact About DO-264 That No One Is Suggesting
The Fact About DO-264 That No One Is Suggesting
Blog Article
Employing Alcoholic beverages or tobacco with particular medicines may bring about interactions to happen. Examine together with your healthcare Expert the use of your medication with food items, Alcoholic beverages, or tobacco.
quinupristin/dalfopristin will enhance the amount or outcome of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug.
quinupristin/dalfopristin will enhance the stage or impact of nicardipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
quinupristin/dalfopristin will improve the amount or influence of omaveloxolone by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
quinupristin/dalfopristin decreases results of typhoid vaccine Are living by pharmacodynamic antagonism. Contraindicated. Wait until eventually Abx Tx total to administer Dwell bacterial vaccine.
Meanwhile, to be sure continued support, we've been displaying the internet site without the need of kinds and JavaScript.
quinupristin/dalfopristin will increase the amount or outcome of sufentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.
quinupristin/dalfopristin will increase the stage or influence of zaleplon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
quinupristin/dalfopristin will improve the stage or influence of erythromycin lactobionate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug.
quinupristin/dalfopristin will enhance the stage or effect of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.
quinupristin/dalfopristin will increase the degree or influence of tazemetostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
There won't be any sufficient reports in women for analyzing toddler danger when working with this medication throughout breastfeeding. Weigh the probable Advantages in opposition to the opportunity pitfalls before taking this medication even though breastfeeding.
quinupristin/dalfopristin will enhance the amount or effect of deflazacort by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Reduce deflazacort dose to one-third in the encouraged dose if coadministered with average or potent CYP3A4 inhibitors.
Watch Intently (one)quinupristin/dalfopristin will enhance the level or outcome of diazepam buccal by influencing hepatic/intestinal enzyme CYP3A4 Usmarapride free base metabolism.